Source-grounded facts extracted from Health In Tech, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Dustin Plantholt departed as Chief AI & Marketing Officer at Health In Tech, Inc..
“Following receipt of formal notice on April 27, 2026, Dustin Plantholt departed from his role as Chief AI & Marketing Officer of Health In Tech, Inc. (the “Company”), effective as of April 30, 2026, as part of a business transition and not as a result of any disagreement with the Company on any matter relating to its operations, policies or practices.”
Health In Tech, Inc. entered into Placement Agency Agreement with Craig-Hallum Capital Group LLC (effective 2026-03-25).
“The Company also entered into a placement agency agreement (the “Placement Agency Agreement”) with Craig-Hallum Capital Group LLC, as the sole placement agent (the “Placement Agent”), dated March 25, 2026, pursuant to which the Placement Agent agreed to serve as the placement agent in connection with the PIPE in consideration for a cash placement fee and the reimbursement of certain out of pocket expenses, including those of its legal counsel.”
Health In Tech, Inc. entered into Registration Rights Agreement with each Purchaser (effective 2026-03-25).
“In connection with the Purchase Agreement, the Company entered into a registration rights agreement (the “Registration Rights Agreement”) with each Purchaser.”
Health In Tech, Inc. entered into Purchase Agreement with certain accredited investors valued at approximately $7.0 million (effective 2026-03-25).
“On March 25, 2026, Health In Tech, Inc., a Nevada corporation (the “Company”), announced that it has entered into a securities purchase agreement (the “Purchase Agreement”) with certain accredited investors (each, a “Purchaser” and collectively, the “Purchasers”) relating to a private investment in public equity financing (the “PIPE”) for an aggregate of 5,600,000 shares of its common stock, par value $0.001 per share (the “Shares”).”
Lynn Liang departed as Director at Health In Tech, Inc..
“On April 12, 2025, Lynn Liang notified the Board of Directors (the “Board”) of Health In Tech, Inc., a Nevada corporation (the “Company”) that she is resigning from the Board effective April 18, 2025.”
Sanjay Shrestha was elected as Director at Health In Tech, Inc..
“elected Sanjay Shrestha to serve as a member of the Board with immediate effect, for a one-year term”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.